Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor.

The human immunodeficiency virus (HIV) fusion inhibitor siamycin I, a 21-residue tricyclic peptide, was identified from a Streptomyces culture by using a cell fusion assay involving cocultivation of HeLa-CD4+ cells and monkey kidney (BSC-1) cells expressing the HIV envelope gp160. Siamycin I is effe...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Lin, P F, Samanta, H, Bechtold, C M, Deminie, C A, Patick, A K, Alam, M, Riccardi, K, Rose, R E, White, R J, Colonno, R J
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1996
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163071/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8787894/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.1.133
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!